Correlation Between MediciNova and Dynavax Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both MediciNova and Dynavax Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MediciNova and Dynavax Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MediciNova and Dynavax Technologies, you can compare the effects of market volatilities on MediciNova and Dynavax Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MediciNova with a short position of Dynavax Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of MediciNova and Dynavax Technologies.

Diversification Opportunities for MediciNova and Dynavax Technologies

0.39
  Correlation Coefficient

Weak diversification

The 3 months correlation between MediciNova and Dynavax is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding MediciNova and Dynavax Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dynavax Technologies and MediciNova is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MediciNova are associated (or correlated) with Dynavax Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dynavax Technologies has no effect on the direction of MediciNova i.e., MediciNova and Dynavax Technologies go up and down completely randomly.

Pair Corralation between MediciNova and Dynavax Technologies

Given the investment horizon of 90 days MediciNova is expected to under-perform the Dynavax Technologies. In addition to that, MediciNova is 3.85 times more volatile than Dynavax Technologies. It trades about -0.1 of its total potential returns per unit of risk. Dynavax Technologies is currently generating about 0.07 per unit of volatility. If you would invest  1,283  in Dynavax Technologies on October 6, 2024 and sell it today you would earn a total of  11.00  from holding Dynavax Technologies or generate 0.86% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

MediciNova  vs.  Dynavax Technologies

 Performance 
       Timeline  
MediciNova 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in MediciNova are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, MediciNova showed solid returns over the last few months and may actually be approaching a breakup point.
Dynavax Technologies 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Dynavax Technologies are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Dynavax Technologies showed solid returns over the last few months and may actually be approaching a breakup point.

MediciNova and Dynavax Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with MediciNova and Dynavax Technologies

The main advantage of trading using opposite MediciNova and Dynavax Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MediciNova position performs unexpectedly, Dynavax Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dynavax Technologies will offset losses from the drop in Dynavax Technologies' long position.
The idea behind MediciNova and Dynavax Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios